metastatic gastric adenocarcinoma
Showing 1 - 17 of 17
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage
Active, not recruiting
- Clinical Stage III Gastric Cancer AJCC v8
- +7 more
- Berzosertib
- +4 more
-
Duarte, California
- +30 more
Jan 7, 2023
HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer Trial in Germany, Spain,
Recruiting
- HER2-positive Breast Cancer
- +4 more
-
Essen, Germany
- +5 more
Nov 15, 2022
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Esophageal
Recruiting
- Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
- +13 more
- Capecitabine
- +5 more
-
Anchorage, Alaska
- +380 more
Jul 26, 2022
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Camrelizumab,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Camrelizumab
- Apatinib Mesylate
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Apr 16, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage III Gastric Cancer AJCC v8
- +30 more
- Paclitaxel
- +3 more
-
Scottsdale, Arizona
- +11 more
Apr 4, 2022
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Japan, Korea, Republic of, Taiwan
Completed
- Metastatic Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- +4 more
-
Akashi, Japan
- +33 more
Feb 23, 2022
Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8
Recruiting
- Advanced Gastric Adenocarcinoma
- +32 more
- Lenvatinib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Mar 2, 2022
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,
Recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Docetaxel
- +2 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +38 more
- Pembrolizumab
- Sonidegib
-
Scottsdale, Arizona
- +2 more
Aug 27, 2021
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,
Completed
- Metastatic Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- +4 more
-
Fayetteville, Arkansas
- +134 more
Jul 29, 2021
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Wuhan (Camrelizumab, Apatinib
Recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Camrelizumab
- +3 more
-
Wuhan, Hubei, ChinaZhongnan Hopital of Wuhan University
May 14, 2021
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA
Recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +16 more
-
Houston, TexasM D Anderson Cancer Center
Apr 30, 2020
Metastatic Gastric Adenocarcinoma Trial in Shenyang (Apatinib, Irinotecan)
Unknown status
- Metastatic Gastric Adenocarcinoma
-
Shenyang, Liaoning, ChinaThe First Hospital of China Medical University
Nov 9, 2019